Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KORU vs GSK✓SelectedUSD · GSKKORU vs GSK performance historyLatest closeAs of+2.93%11/18
Stock and ETF performance explorer

KORU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-63.2%
GSK return
+100.6%
Excess return
-163.8%
Maximum drawdown
-95.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.9%-1.3%+4.3%+4.0%
7D-21.9%-3.1%-18.8%-19.8%
30D-44.0%-0.9%-43.1%-44.4%
3M-62.6%-4.2%-58.4%-62.4%
6M-81.3%-1.6%-79.7%-82.9%
YTD-26.5%+2.6%-29.1%-35.4%
1Y-8.8%+6.2%-15.0%-22.5%
3Y+81.9%+55.0%+26.9%-5.6%
5Y-41.8%+42.8%-84.6%-68.3%
10Y-29.9%+102.1%-132.0%-72.2%
All-63.2%+100.6%-163.8%-81.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling